TotalMarketCap

Charles River Laboratories International

CRLNYSE United StatesHealth CareBiotechnology: Commercial Physical & Biological Resarch

Market cap

$15.049 B

$314.07 -3.75%

Close of 6 Nov 2026

As of 6 Nov 2026, Charles River Laboratories International (CRL) has a market capitalization of $15.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.02B

#773 by revenue

Earnings

-$144.3M

Loss-making

Shares outstanding

47,917,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →
  1. #3MedpaceMEDP$17.7B
  2. #4IconICLR$15.4B
  3. #5Charles River Laboratories InternationalCRL$15.0B
  4. #6AbsciABSI$1.61B
  5. #7OmniAbOABI$706.7M

What if Charles River Laboratories International were worth as much as…

Open the what-if tool →

Gold $28.2T

$589,281.44

Per share 1,876× higher

Bitcoin $1.53T

$31,884.99

Per share 102× higher

Apple $5.02T

$104,675.45

Per share 333× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Charles River Laboratories International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.